Delivery Order SPE2DB20D3101-SPE2DB23FRWP9
Award Date
9/5/23
Potential Completion Date
9/26/23
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,421.76 and is a Firm Fixed Price Delivery Order that runs through March 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract, awarded to AmerisourceBergen Drug Corp's Corporate Office Division, has a ceiling value of $5,958.56 and a completion date of July 23, 2024. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant...
This federal contract award is for the delivery of RYANODEX 250 MG VIALS to the Medical Supply Chain division of the Defense agency. The award, valued at $4,468.92, was issued to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a completion date of June 17, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of RYANODEX 250 MG VIALS to the Defense Logistics Agency (DLA). The $2,979.28 firm-fixed-price contract has a completion date of July 11, 2024. This delivery order falls under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $22,344.60, is for the delivery of RYANODEX 250 MG VIALS to the agency. This is a firm fixed price delivery order contract with a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,816.32, is a delivery order for 4567143430 RYANODEX 250 MG VIALS. The contract has a firm fixed price pricing type and an ultimate completion date of February 24, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This federal contract award, valued at $16,386.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of RYANODEX 250MG VIAL 1S, a pharmaceutical product, with a completion date of November 8, 2024. The award is not associated with a set-aside program and is a firm-fixed-price delivery order contract. Amerisourcebergen Drug Corp is a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,605.44, is for the delivery of RYANODEX 250MG VIAL 1S medical supplies. The contract has an ultimate completion date of February 12, 2025 and is a Firm Fixed Price Delivery Order. There is no set-aside designation indicated for this award. Amerisourcebergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of RYANODEX 250 MG VIALS, a pharmaceutical product, with a ceiling value of $9,632.64. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of April 4, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This contract award to Amerisourcebergen Drug Corp is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $22,476.16. The contract is for the supply of RYANODEX 250 MG VIALS, a pharmaceutical product, to support military healthcare programs. The IDC with the DLA Troop Support Medical has a ceiling value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and...